Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-30 | Edward J. Zelnick, M.D., Director since 2015. No compensation information provided. |
| 2016-04-15 | Edward J. Zelnick, M.D. has been a medical doctor for over 45 years and has a background in clinical research. The Compensation Committee is comprised of three members, Leonard M. Schiller, Leslie Bernhard and Edward J. Zelnick, M.D. The Audit Committee is comprised of Leslie Bernhard and Leonard M. Schiller, and Edward Zelnick, M.D. The Board formed a Nominating and Corporate Governance Committee in May 2004. The members of the Nominating and Corporate Governance Committee are Leonard M. Schiller, Leslie Bernhard and Edward J. Zelnick, M.D. Director Compensation: Edward J. Zelnick, M.D. $33,000. |
| 2017-04-12 | Edward J. Zelnick, M.D. (1) (3) (5) 71 Director 2015 (1) Member of the Audit Committee. (3) Member of the Nominating Committee. (5) Chairman of the Nominating Committee. Director Compensation: Edward J. Zelnick, M.D. $33,000 |
| 2018-04-30 | Edward J. Zelnick, M.D. (1) (2) (3) 72 Director 2015 1. Member of the Audit Committee 2. Member of the Compensation Committee 3. Member of the Nominating and Corporate Governance Committee Director Compensation Edward J. Zelnick, M.D. Fees Earned or Paid in Cash ($) 36,000 Bonus Paid in Stock 26,600 Total 62,600 Edward J. Zelnick, M.D. has been a director of Milestone Scientific since February 2015. Dr. Zelnick has been a medical doctor for over 45 years and has a background in clinical research. Since June 2002 he has been the chief executive officer of Horizon Institute for Clinical Research, a company that recruits test subjects and clinicians for clinical research trials. Dr. Zelnick received a Bachelor of Science degree in chemistry from the University of Pittsburgh in 1966 and his M.D. degree from New York Medical College in 1970. Dr. Zelnick's professional experience and background as a medical doctor and in clinical research, have given him the expertise needed to serve as one of our directors. |
Data sourced from SEC filings. Last updated: 2025-12-07